Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (Mrd) With Early Priority Date
萬基遺傳宣佈第三個分子殘餘疾病(Mrd)專利獲批,具有較早的優先日。
Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (Mrd) With Early Priority Date
萬基遺傳宣佈第三個分子殘餘疾病(Mrd)專利獲批,具有較早的優先日。
譯文內容由第三人軟體翻譯。